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Abstract
The largest of the cranial ganglia, the trigeminal ganglion relays cutaneous sensations of the head
to the central nervous system. Its sensory neurons have a dual origin from both ectodermal
placodes and neural crest. Here, we show that birth of neurons derived from the chick ophthalmic
trigeminal placode begins prior to their ingression (HH11), as early as HH8, and considerably
earlier than previously suspected (HH16). Furthermore, cells exiting the cell cycle shortly
thereafter express the ophthalmic trigeminal placode marker Pax3 (HH9). At HH11, these post-
mitotic Pax3+ placode cells begin to express the pan neuronal marker, neurofilament, while still in
the ectoderm. Analysis of the ectodermal origin and distribution of these early post-mitotic
neurons reveals that the ophthalmic placode extends further rostrally than anticipated, contributing
to neurons that reside in and make a significant contribution to the ophthalmic trigeminal nerve.
These data redefine the timing and extent of neuron formation from the ophthalmic trigeminal
placode.
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Introduction
The trigeminal ganglion, providing cutaneous sensory innervation for much of the face, is
comprised of two distinct lobes that differ in morphology and projection patterns. The
ophthalmic lobe innervates the forehead, eyes, and nose, whereas the maxillomandibular
innervates the jaw, teeth, and tongue. Although the later steps of ganglion formation and
guidance of trigeminal axons to their targets have been studied extensively (rev. Baker and
Bronner-Fraser, 2001), less is known about early events governing neuronal differentiation,
distribution and aggregation. The trigeminal ganglion owes its embryonic origin to two
different cell populations—trigeminal placode and neural crest. Whilst placode cells
uniquely form sensory neurons, neural crest contributes to both sensory neurons and glia. In
birds, these two cell populations intermix but are morphologically distinguishable for the
first two weeks of development by size and location (D’Amico-Martel and Noden, 1980).
When and how does the trigeminal ganglion begin to form? Previous studies have shown
that secreted factors from the dorsal neural tube induce the ophthalmic trigeminal (opV)
placode (Stark et al., 1997; Baker et al., 1999) in a manner that requires Platelet Derived
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Growth Factor signaling (McCabe and Bronner-Fraser, 2008). In chick, this induction
process begins around HH8 (Stark et al., 1997; Baker et al., 1999) and ectoderm becomes
specified to express Pax3 protein, a molecular marker for opV placode, around HH9 (8ss)
(Baker et al., 1999). Pax3 mRNA is expressed in the presumptive forebrain/midbrain neural
folds as early as HH8 in embryos with four somite pairs (Stark et al., 1997). Individual opV
placode cells express Delta-1, Brn3a, and the tetraspanin CD151 around HH10 (Begbie et
al., 2002; McCabe et al., 2004). The first opV placode cells ingress as spurs or individual
cells at HH11 (D’Amico-Martel and Noden, 1983) and express the neuronal marker, β-
tubulin by HH13 in the placodal ectoderm and forming opV ganglion (Moody et al., 1989).
DiI labeling of the surface ectoderm at HH11 has shown that, in addition to their well known
origin from midbrain level ectoderm (D’Amico-Martel and Noden, 1980; Xu et al., 2008)
placodal opV neurons also arise from caudal forebrain (Lee et al., 2003). By HH14–16,
ingressing opV placode cells are numerous and conspicuous, apparently completing
ingression by HH21 (D’Amico-Martel and Noden, 1983).
The early appearance of neuronal markers in the opV placode even prior to ingression raises
the intriguing possibility that some placode cells may be post-mitotic while still in the
ectoderm. However, surprisingly little is known about their earliest time of cell cycle exit.
To help interpret emerging molecular information on trigeminal placode development
(McCabe et al., 2004, 2007), it is important to determine the link between cell cycle exit and
processes of induction and specification. D’Amico-Martel and Noden (1980) reported that
trigeminal placode cells contributing to the maxillomandibular (mmV) lobe first exit the cell
cycle at HH16 and continue becoming post-mitotic through HH30, when only satellite cells
are labeled. Although almost all data presented was for the mmV lobe, their summary
diagram suggested that birth of opV placode cells may be similar. More recent work (Begbie
et al., 2002) reports that ingressing opV placode cells at HH13 lack phosphohistoneH3, a
marker for dividing cells (Hendzel et al., 1997), suggesting that they may be born at earlier
stages than previously thought.
To rigorously evaluate the birthdate of opV placode cells, we combine labeling with 3H-
Thymidine (3H-Thy) and bromodeoxyuridine (BrdU), with molecular markers, to show that
cell cycle exit and differentiation initiates within the early placode prior to ingression and
that the opV placode extends more rostrally than previously thought. These data form a
critical framework for understanding molecular aspects of ophthalmic trigeminal ganglion
formation as well as interpreting events leading to malformations of the ganglion or
misroutings of the opV nerve in the adult.
Methods and Materials
3H-Thymidine and BrdU labeling
Embryos were staged according to Hamburger and Hamiliton (1951) for 3H-Thymidine
(New England Nuclear; 6.7 Ci/mmol) and BrdU (Sigma) labeling. Embryos received two,
50λ injections of 10–40 µCi of 3H-Thymidine in PBS (pH 7.4) separated by 3 hours, to
provide complete coverage for all dividing cells, and incubated until desired stage at 37°C
(n= 2 for HH6–7 (headfold- 2 somite stage (ss)), n=1 for HH8 (3–5ss), n=1 for HH10 (9–
11ss), n=2 for HH11 (12–14ss), n=1 for HH12 (15–17ss), n=2 for HH14 (21–23ss)).
Fixation and autoradiography was performed as previously described (Sechrist and Bronner-
Fraser, 1991; Sechrist and Marcelle, 1996).
All 3H-Thymidine sections were counterstained with Toluidine blue to allow identification
of cytoplasm from nuclei and nucleoli. Cytoplasmic material stains a darker shade of purple
than the nucleus. The circular nuclei are seen as a lighter shade of purple with intensely
purple spots that mark the nucleoli within the nucleus. Note that sections are 1 µm thin, and
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therefore do not always contain a nucleus. When this occurs, serial sections are consulted to
determine the labeling of a given nucleus with silver grains. Determination of level of
labeling was done on a case by case basis as changes in exposure time of autoradiography
changes the apparent density of silver grains. Heavily labeled cells were actively dividing at
the time of application. Some cells had significantly lighter label and may have been at the
end of their final DNA synthesis phase and the second application of 3H-Thymidine three
hours later during what would have been another S phase was not incorporated. These cells
were counted as dividing. Cells that contained no grains above background silver grains
were considered to have exited the cell cycle.
In order to co-label cells for cell division and molecular markers, the thymidine analog,
bromodeoxyuridine (BrdU) (40–75 λ of 10–100 µM BrdU) was applied directly to the
embryos, twice in a 2–3 hour interval to ensure that all cells undergoing DNA synthesis
would be labeled, and incubated until desired stage at 37°C (n=5 for HH6–7, n=8 for HH8,
n=8 for HH9 (6–8ss), n=9 for HH10). Cumulative labeling experiments described above
mark all dividing cells at the time of application. On the other hand, the pulse labeling
experiments described below give a quick snap shot of those cells in S phase for 30 minutes.
For pulse labeling experiments embryos were exposed to BrdU for 30 minutes, and then
immediately fixed in 4% paraformaldehyde at room temperature for 4 hours (n=1 for HH9,
n=2 for HH10, n=5 for HH11, n=5 for HH12, n=8 for HH16 (28–30ss)). Embryos were
cryoprotected and cryosectioned at 8 µm as previously described (Sechrist et al., 1995) with
the exception of the Pax3 images in Figure 2 which were cut at 10 µm.
Digital Photography
All DIC photographs were taken using the Zeiss Axioskop2 using the Axiocam HRC digital
camera. All fluorescent images were taken using the Zeiss Axioskop2 Plus using the
Axiocam mRM digital camera with the following exceptions which were photographed on
35mm slide film on the Olympus Vanox microscope: Figure 2C and Figure 3I–K. 35mm
slides were scanned into digital format using the Epson Perfection 3200 photo or Agfa Snap
Scan 310. All figures were adjusted for optimal brightness and contrast in Photoshop 7.0.
Images were subsequently imported into Illustrator 10 to apply labels. Some color change
was noticed during the importation and was subsequently adjusted back to the levels original
to the Photoshop images.
Immunostaining
Immunostaining was performed as described (Sechrist et al., 1995) with the exception of the
boric acid treatment for BrdU staining (P. Strobl, personal communication). Sections were
subjected to 2N HCl in PBS for 30 minutes at room temperature, 0.1 M Boric Acid pH 6 in
PBS for 20 minutes, and rinsed in PBS three times prior to immunostaining. Primary
antibodies were used at the following concentrations: BrdU (Sigma, 1:1000),
Phosphohistone H3 (Upstate biotechnology, 1:250), HuC/D (Invitrogen, 1:200),
Neurofilament 145 kDa (Chemicon, 1:500), Pax3 (Developmental Hybridoma Bank, 1: 10).
Secondary antibodies conjugated with Alexa 488 and 568 (Molecular Probes) were used at
1:1000 (Goat anti-rabbit and Goat anti-mouse IgG1, IgG2a, IgG2b). For detection of nuclei,
DAPI (Sigma) at 2 µg/ml in PBS for 10 minutes at room temperature.
The identification, specificity, and controls for each primary antibody utilized are as
follows: Anti-BrdU is a mouse antiserum (Sigma #B-2531, Lot 074H4814) prepared against
BromodeoxyUridine conjugated to KLH. The specificity of the antiserum was tested by
Elisa, flow cytometry, and no BrdU controls (Gratzner, 1982; Meyer et al., 1989). Anti-
PhosphoHistone H3 is a rabbit polyclonal (Upstate Biotechnology # 06-570, Lot
DAM1416518) prepared against peptide ARKpSTGGKAPRKQLC corresponding to amino
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acids 7–20 of human histone H3. The antibody stains a single band of 17kDa molecular
weight on Western blot (manufacturer’s technical information). Controls were done by
Western blot on acid extracts of colcemid treated and untreated human HeLa cell lines. Anti-
HuC/D is a mouse monoclonal (Invitrogen #A21271, Lot 43471A) prepared against Human
peptide QAQRFRLDNLN-C-Keyhole Limpet Hemocyanin conjugate. The antibody stains
three Hu bands, HuDpro, HuD, and HuC in human cortical neuronal extracts. The HuC/D
does not bind to the HuDmex peptide that is missing the immunized domain or unrelated
proteins (Marusich et al., 1993). Anti-Neurofilament is a rabbit polyclonal (Chemicon
#AB1987, Lot 0512018314) prepared against the recombinant fusion protein containing the
C-terminal 168 amino acids of rat NF-M. The antibody stains a single band at 145kDa
molecular weight on chicken brain extract on Western blot (Harris et al., 1991). This
antibody provides the same staining in the developing chick retina as the antibody,
RMO270, a mouse monoclonal against NFM (McCabe et al., 1999; McCabe et al., 2005).
Anti-Pax3 is a mouse monoclonal (Developmental Hybridoma Bank #Pax3) prepared
against the recombinant fusion protein containing C-terminal region (amino acid #298-481)
of Quail Pax3. The antibody stains a single band at approximately 60 kDa on E3 chicken
neural tube and notochord extract on Western blot (Venters et al., 2004). The expression of
Pax3 protein is similar to previously reported mRNA (Stark et al., 1997; Baker et al., 1999).
DiI labeling
In order to label the surface ectoderm without labeling the neural tube or neural crest, whole
embryos were labeled with 0.5% DiI (Molecular Probes) after cranial neural tube closure
(HH10) as previously described (Sechrist et al., 1995; Stark et al., 1997).
Results
Cumulative labeling of embryos with 3H-Thy or the thymidine analog, BrdU, was
performed at stages ranging from HH7–14 to determine the time and location that the first
opV placode cells cease DNA synthesis using established criteria (Sidman, 1970). To
achieve cumulative labeling, two doses of 3H-Thy or BrdU were applied 3hrs apart to ensure
uptake by all dividing cells when the cell cycle time is approximately 8hrs (Langman et al.,
1966; Sechrist and Bronner-Fraser, 1991). Embryos were collected at selected intervals
between 10 and 32 hours of total incubation times. Initial experiments were performed
with 3H-Thy, as it has several advantages. First, it is readily incorporated at non-toxic
concentrations, allowing for embryo collection after longer incubation periods. Second, 3H-
Thy treated embryos can be embedded in plastic and sectioned at 0.5–1µm allowing for high
resolution analysis and exact identification of 3H-Thy incorporation by nuclei. Third, the
amount of incorporation can be analyzed by grouping the cells into 3 classes: no label, light
label or heavy label. On the other hand, BrdU labeling offers the possibility of performing
double antibody labeling. BrdU labeling also provides relatively quick verification of data
obtained from 3H-Thy labeling.
All 3H-Thy sections were counterstained with Toluidine Blue to allow for identification of
cytoplasm, nuclei, and nucleoli. Cytoplasm is characterized by its darker purple stain, while
nuclei are a lighter purple and circular in shape within the cytoplasm. In addition, nucleoli
show up as intensely dark purple spots within the nucleus. Since the sections are only 1 µm
thick, there are instances where the nucleus will appear on an adjacent section. To verify the
lack of label, serial sections were examined to clearly identify cells that contain a nucleus
and whether this nucleus is labeled with silver grains. Notably, many nuclei are heavily
labeled and are easily identifiable as actively dividing at the time of 3H-Thy application.
However, there are two additional classes of cells, those that are lightly labeled and those
that are unlabeled. Lightly labeled cells were identified as having significantly fewer grains
of silver above background than heavily labeled cells. These cells are likely lightly labeled
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due to only incorporating 3H-Thy during the first application and exiting the cell cycle
before the second application three hours later. None the less, these cells were identified as
actively dividing at the time of application. Only cells with no grains above background
levels were classified as post-mitotic.
Some opV placode cells become post-mitotic in the ectoderm at HH8
We tested when the first opV placode cells exit the cell cycle. Exposure of embryos to 3H-
Thy or BrdU at HH7 resulted in labeling of all cells, indicating that presumptive opV
placode cells have yet to exit the cell cycle; e.g., an embryo treated with 3H-Thy at HH7 and
allowed to develop to HH13 has ophthalmic placode cells in the process of delaminating
from the ectoderm at midbrain and rostral hindbrain levels (Figure1A–C); their parent cells
were still actively dividing as indicated by silver grains over the nuclei. Similar data were
obtained using BrdU labeling (Figure4A–C). This suggests that few if any opV precursor
cells have ceased dividing at HH7.
Interestingly, application of either 3H-Thy or BrdU at HH8 revealed a few scattered cells in
the presumptive opV placode that have exited the cell cycle. From the middle forebrain to
rostral hindbrain, ≥45 cells within the dorsolateral ectoderm and adjacent mesenchyme
lacked 3H-Thy incorporation (summarized in Figure1D). Figure1E–H show delaminating
placode cells at the forebrain, rostral and middle midbrain levels that have failed to
incorporate 3H-Thy (arrow). However, most opV placode cells have not yet begun to exit
the cell cycle at rostral hindbrain levels (arrowhead; Figure1I). In contrast, labeling at HH10
yields increased numbers of post-mitotic cells (≥85) including some that have ingressed at
more caudal levels (Figure 3A,B). These results suggest that there is a rostrocaudal gradient
of cell cycle exit with more rostral opV cells being born first (Figure 1E–I), and cells at the
level of the caudal midbrain/rostral hindbrain generated somewhat later (Figure1H–I,
Figure3C–G).
Distribution of post-mitotic cells suggests a rostral extension of the opV placode
To assess the distribution of opV precursors throughout the ectoderm, we systematically
analyzed all available cranial sections through an embryo treated with 3H-Thy at HH8 and
collected at HH12. The region of interest included 80 slides with approximately 15 sections/
slide at 1µm thick. The position of unlabeled cells within the ectoderm (red circle) or
adjacent mesenchyme (green triangle) were marked according to their rostrocaudal and
mediolateral locations relative to forebrain, midbrain, and rostral hindbrain (Figure1D).
Ingressing ectodermal cells and cells beginning to condense to form the trigeminal ganglion
and nerve were classified as mesenchymal. These earliest post-mitotic cells extended from
mid-forebrain to rostral-hindbrain levels. From medial to lateral, the unlabeled cells were
found above and lateral to the neural tube (Figure1E) within the Pax3 protein expression
domain (Figure2G–I). Figure1E shows at least three clustered cells that are 3H-Thy
negative, two of which have ingressed from the ectoderm at the caudal forebrain/rostral
foregut level. Additional individual cells at the rostral midbrain level can be seen exiting the
ectoderm (Figure 1F–G). Slightly later (HH10 label, collected at HH15), there are two 3H-
Thy negative cells in the mesenchyme at the level of the forebrain corresponding to the
presumptive path on which the ophthalmic nerve will project (Figure 2A–B). Initially, their
position is dorsal to the eye but shifts medially at later stages. To confirm that these post-
mitotic cells are neurons, we treated an embryo at HH9 (collected at HH15) with BrdU.
Similar BrdU- cells were noted between the eye and forebrain expressing neurofilament
(NFM); note NFM nerve fibers (green) surrounding the DAPI (blue) stained nuclei lacking
BrdU (red; Figure2D–F). Using the trigeminal placode marker Pax3 at HH9–11, we find
Pax3+ placodal ectodermal cells at the level of the forebrain (Figure 2G–I), further
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supporting the idea that the trigeminal placode extends to the caudal forebrain level
ectoderm.
To verify the site of origin of these cells, we labeled the ectoderm at HH11 with DiI, after
neural tube closure. This allows complete labeling of ectoderm but not the neural tube or
neural crest. Accordingly, any DiI positive cells within the mesenchyme are ectodermally
derived and therefore of placodal origin. Figure2C shows DiI-labeled ectoderm at HH11,
processed at HH14. Several cells have migrated in a stream, delaminating at the forebrain
level (Figure2C), and localizing in the vicinity of the future ophthalmic nerve. Thus, DiI-
labeled placode cells from rostral ectoderm contribute neuronal cell bodies to the opV nerve.
Co-staining with neurofilament antibodies (data not shown) verifies that these cells
selectively contribute to neurons along the ophthalmic nerve.
Analysis of serial sections through embryos treated at HH10 and HH14 confirms that post-
mitotic neuronal cell bodies lie along the opV nerve. Some of these scattered cells at eye
level or just caudal to the eye are found as individuals or in strands of two to four cells (data
not shown). An embryo treated at HH10 and collected at HH15 shows more post-mitotic
cells within the condensing opV nerve/ganglion level caudal to the eye (Figure 3A–B). In an
older embryo, treated at HH14 and collected at HH16, still more post-mitotic cells are found
within the condensing opV ganglion region (Figure 3C–D). Even later, in an embryo treated
at stage HH14, but collected at HH18 when the condensing trigeminal ganglion and opV
nerve are easily identifiable (Figure 3E–G), post-mitotic cells are detectable within the opV
nerve. The many 3H-Thy labeled nuclei adjacent to and within the opV nerve likely
represent dividing neural crest cells. To confirm that these post-mitotic cells within the
forming opV nerve are indeed neurons, embryos were stained with the neuronal marker Hu.
In an HH17 embryo in a section at forebrain level, just caudal to the eye, Hu+ neurons in the
opV nerve can be detected (Figure 3H) in a location rostral to those shown in the latter 3H-
Thy treated embryos (Figure 3E–F). The number of Hu+ neurons counted in one ophthalmic
nerve at E3 (HH18+) was more than 40 between the opV ganglion and eye level (data not
shown). To determine if these cells persist within the ophthalmic nerve, sections were
stained with NF to identify the opV nerve and co-stained with Hu to determine if neuronal
cell bodies were present within the nerve. At HH24 (E4.5), Hu+ neuronal cell bodies are
easily identifiable within the opV nerve (NF+) (Figure 3I–K). Thus, ectodermal trigeminal
placodal cells give rise to neurons that persist in the maturing trigeminal ophthalmic nerve.
Cells post-mitotic at HH8 acquire opV placode markers
BrdU labeling allows examination of expression of molecular markers characteristic of the
opV placode (Pax3, NF, Hu) in cells that have or will soon exit the cell cycle. As with 3H-
Thy, all trigeminal placode cells incorporate BrdU at HH7 (Figure4A) and express Pax3
within the placodal ectoderm by HH9–10 (collected at HH10) (Figure4B,C). Migrating
neural crest transiently express Pax3 in the mesenchyme at HH10. Several hours later, a few
BrdU- cells were found in the Pax3+ ectoderm and mesenchyme (labeled at HH8, collected
at HH13; Figure4D–F). Increasing numbers of Pax3+/BrdU- cells were seen in
progressively older embryos when incubated with BrdU (labeled at HH9–10, collected at
HH16; Figure4G–L).
The relationship between BrdU uptake and onset of neuronal properties was examined by
neurofilament (NFM) expression. As early as HH8 (collected at HH13), a few NFM+/BrdU-
cells can be detected (arrow, Figure5A–C, C’’) though the majority of cells are NFM+/BrdU
+ (arrowhead, Figure 5A–C, C’). Interestingly, some cells have light BrdU labeling,
indicating that they are in transition (Figure 5B, C’, arrowhead). Labeling at HH9–10
(collected at HH15) yields a mixture of NFM+/BrdU+ and NFM+/BrdU- (Figure5D–I’’).
The results suggest that not all opV placode cells become post-mitotic simultaneously.
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While some exit the cell cycle very early and within the placode, others continue to divide
for some time.
OpV placode cells are post-mitotic when they initiate expression of neuronal markers
Are cells expressing molecular markers for opV placode cells such as Pax3 and NFM
actively cycling, or do they exit the cell cycle and then express these markers? To address
this question for the opV placode, either phosphohistoneH3 (PH3) or a short pulse of BrdU
were applied to HH9–10 embryos, by which time many opV placode cells are expressing
Pax3, to identify actively cycling placodal cells. In contrast to the cumulative labeling
experiments, which label all dividing cells during the application, pulse labeling provides a
snapshot of time. With a 30 minute application of BrdU, cells undergoing S phase during
that time will be labeled. This is balanced with the idea that the cells should not have time to
substantially alter protein expression or their physical location.
With rare exceptions, we observed that few Pax3 expressing cells co-express PH3 (data not
shown). Because PH3 only marks a subset of the actively dividing cells in mitosis, we also
labeled HH9–10 embryos with a short pulse of BrdU (30min.) to identify cells undergoing
DNA synthesis and fixed them immediately. Since S phase lasts longer than M, more
actively dividing cells are detectable by BrdU than PH3. Interestingly, embryos treated with
a short pulse of BrdU yielded both Pax3+/Brdu- and Pax3+/Brdu+ cells (Figure6A–C). The
results show that trigeminal placode cells can continue to divide after expressing the
specification marker, Pax3 while still in the ectoderm. However, once the placodal Pax3+
cells are in the mesenchyme (starting at HH11), they no longer are dividing (data not
shown). The cells that are Pax3 positive within the mesenchyme at HH10 are migrating
neural crest cells, which will soon turn off Pax3 expression. The co-labeling of Pax3 with
BrdU suggests that some opV placode cells continue to divide at least once even after they
initiate expression of the molecular marker Pax3, whereas others are post-mitotic as
substantiated by the cumulative labeling experiments (Figure4D–L).
We tested whether dividing opV cells expressed neurofilament (NFM) within the placodal
ectoderm and the mesenchyme. We found NFM+ cells are readily identified in the ectoderm
and mesenchyme at HH11 (13ss), when opV placode cells first delaminate and enter the
mesenchyme (D’Amico-Martel and Noden, 1983; Figure6D–F). When the opV ganglion is
well condensed but prior to differentiation of neural crest-derived neurons (HH18), the
neuronal marker HuC/D was used to label placodal derived neurons. All HuC/D+ cells are
BrdU- indicating that all opV neurons within the condensed ganglion have exited the cell
cycle by this stage (Figure6G–I). However, opV placode cells are still being generated
within the ectoderm at this stage (data not shown, D’Amico-Martel and Noden, 1980). Our
results support the conclusion that some opV cells are post-mitotic very early (HH8) within
the placodal ectoderm whereas others continue to be generated throughout gangliogenesis
upto HH21 (D’Amico-Martel and Noden, 1980).
Discussion
We find that cells of the presumptive opV placode are actively dividing prior to HH7, but
begin exiting the cell cycle as early as HH8 (4ss) and become specified to express Pax3 at
HH9–10. However, by the time the first opV placodal neurons delaminate and enter the
mesenchyme around HH11, they are no longer dividing. Although specification of the opV
placode and expression of Pax3 does not dictate cell cycle exit, it correlates with expression
of neuronal markers, NFM and HuC/D, as well as delamination from the ectoderm. Our data
suggest that the boundary of the trigeminal placode, previously thought to be the mid-
midbrain to rostral hindbrain level, actually includes cells that give rise to neurons within the
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opV nerve. As such, ectodermal placode precursors arise in ectoderm as far rostrally as the
middle forebrain level.
Early cell cycle exit
We determined the exact timing and nature of the exit of opV placode cells to resolve
discrepant information from the literature. Cell cycle exit for opV placode cells previously
was proposed to occur from HH13 (Begbie et al., 2002) to as late as HH16 (D’Amico-
Martel and Noden, 1980). Many important molecular and cellular events such as
specification (Baker et al., 1999) and neurogenesis (Moody et al., 1989; Begbie et al., 2002)
are occurring before and during this time period of HH13–16. In order to accurately interpret
these processes, it is critical to know when the cells exit the cell cycle.
By using two different methods, 3H-Thy and BrdU labeling, we show that opV placode cells
exit the cell cycle starting at HH8 (4ss). At HH6–7, we detect no unlabeled opV placode
cells, indicating that these cells are actively dividing. It seems unlikely that the cumulative
labeling method fails to detect slowly dividing cells at HH8. First, the cumulative labeling
technique for both 3H-Thy and BrdU labeled all cells at HH6–7. Second, post-mitotic cells
were first detected at HH8 and continuously increased in numbers at subsequent stages.
Third, there was a small time gap (HH8–H10/11) between when cells exit the cell cycle and
begin to express neuronal markers such as Brn3a and Neurofilament (Begbie et al., 2002;
this paper). Because unlabeled cells (post-mitotic) were detected by HH8 whereas the first
placode cells delaminate at HH11 (D’Amico-Martel and Noden, 1983), the results indicate
that many opV cells cease dividing well before they begin to ingress from the placodal
ectoderm ≥14 hours later at HH11. Additionally, the apparent random distribution of
scattered post-mitotic placode cells is similar to dispersion of trigeminal placode cells that
has been documented for the trigeminal placode cells at the midbrain and rostral hindbrain
levels by transplant studies (D’Amico-Martel and Noden, 1983), mRNA and antibody
staining of Pax3 (Stark et al, 1997; Baker et al., 1999), and DiI fate map studies (Xu et al.,
2008). Thus, our data suggest that a significant population of opV placode cells are exiting
the cell cycle even at HH8.
Cell cycle exit and molecular markers
We correlated the expression of molecular markers with exit of placodal cells from the cell
cycle. Previously, Begbie et al. (2002) reported opV placode cells in the mesenchyme at
HH13 were not actively cycling as assayed using phosphohistoneH3 and the neuronal
marker Islet1. Moody and colleagues (1989) suggested that trigeminal placodal cells did not
express the neuronal marker for β-tubulin, TUJ1, until their last cell division. In contrast,
some CNS populations can express neuronal markers prior to becoming post-mitotic; e.g.
NFM and phosphohistoneH3 are expressed in cycling precursors in the developing retina
(McCabe et al., 1999). However, early reticular neurons in the brainstem clearly express
NFM after they become post-mitotic (Sechrist and Bronner-Fraser, 1991). Therefore we
asked if post-mitotic opV placode cells expressed Pax3 and the neuronal markers of Hu and
neurofilament. Interestingly, Pax3, which is expressed in specified opV placode cells (Baker
et al., 1999) was found in both actively dividing and quiescent cells. This implies that
specification occurs before the final cell division for some opV placode cells. In relation to
neurogenesis, only post-mitotic opV placode cells expressed the neuronal markers of Hu and
neurofilament. This suggests that although specification occurs around the time of cell cycle
exit, the expression of neuronal markers occurs only after the final cell division.
Furthermore, all ophthalmic trigeminal placode cells appear to be post-mitotic once they are
in the mesenchyme.
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We present the previously undocumented finding that opV placode cells express
neurofilament while still in the ectoderm at St. 11 (13ss). This implies that the opV placode
initiates neurogenesis earlier than other placodes; e.g. the olfactory placode begins
neurogenesis at HH13 (Fornaro et al., 2001), epibranchial at HH13–16 (Begbie et al., 1999;
Begbie et al., 2002), and otic placode at HH12 (Li et al., 2004).
Rostral extension of opV placode and formation of opV nerve
Surprisingly, we found that some post-mitotic opV placode cells originate further rostrally
than indicated by recent fate map studies (Xu et al., 2008). These include cells within the
ectoderm adjacent to caudal forebrain and rostral midbrain. Many of these rostral precursors
contribute neuronal cell bodies to the opV nerve. Previous work by Covell and Noden
(1989) found that some early placode derived neurons are scattered beside the midbrain and
above the optic vesicle rather than incorporated into the opV ganglia proper. They
hypothesized that these cells eventually shift caudally to become part of the condensing
ganglion. However, our data suggest these neurons arise from a rostral extension of the opV
placode, adjacent to the forebrain and rostral midbrain.
Interestingly, Hamburger (1961) performed ablation experiments of the placodal ectoderm at
variable levels between the eye and otic placode and found this often resulted in ectopic
placodal ganglia. Intriguingly, some of these appeared as strings of neurons along the
nerves. Hamburger postulated that this could be due to regeneration or incomplete
extirpation. Our data support the latter interpretation that these ablations were incomplete,
and perhaps when the placodal ectoderm from the caudal forebrain and rostral midbrain are
left intact, the rostral part of the opV nerve forms in the absence of the trigeminal ganglion.
Similarly, D’Amico-Martel and Noden (1983) used chick-quail transplantation to map the
origin of trigeminal neurons. In order to obtain consistent labeling of the trigeminal
ganglion, the ectoderm transplant included ectoderm from adjacent to the caudal midbrain.
When grafts adjacent to the caudal forebrain and rostral midbrain failed to incorporate label
in the trigeminal ganglion, it was assumed that those regions are not part of the ophthalmic
trigeminal placode. However, incorporation of these cells into the ophthalmic trigeminal
nerve was not examined in detail and may have been missed, later as confirmed by Covell
and Noden (1989). Brn3a expression at HH10 also shows individual opV placode cells at
rostral as well as caudal midbrain levels (Begbie et al., 2002). Our data support the existence
of this apparent post-mitotic population and, additionally, provide evidence that these
neurons arise from a rostral extension of the opV placode, adjacent to the caudal forebrain
and the rostral midbrain and are maintained in the mature ophthalmic nerve. An intriguing
possibility is that these cell bodies within the forming nerve may act as “pioneer” neurons,
guiding neurite extension from the ganglion proper.
An additional line of evidence for the rostral extension of the trigeminal placode arose from
examination of the trigeminal placode marker Pax3. Although the mRNA for Pax3 in the
caudal forebrain and rostral hindbrain was previously published (Stark et al., 1997), until
now, this expression has been overlooked. In light of the experiments presented here, it
becomes apparent that many of those Pax3+ cells are in fact trigeminal placode cells. It is
important to note that although Pax3 is thought of as a marker of specified trigeminal
placode cells (Baker et al., 1999), a subpopulation of the cells that initially express Pax3
likely execute the trigeminal placode program. This may explain why the population of
trigeminal placode cells exiting the cell cycle appear randomly scattered throughout the
ectoderm of the head.
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Conclusion
The results reveal several previously unknown properties of the forming opV ganglion and
nerve. First, opV placode cells exit the cell cycle early in development, at a time when the
majority of embryonic cells are actively dividing. Second, these cells differentiate into
neurons shortly thereafter. Third, unlike other peripheral nerves originating from trunk
dorsal root ganglia, placode-derived neuronal cell bodies populate the forming opV nerve.
The data presented here represent a strong foundation upon which future molecular data
regarding trigeminal ganglion formation can be interpreted. Determining the relationship of
cell cycle exit to the time of action of growth factors and transcription factors is a critical
step for understanding induction and specification of the trigeminal placode cells, whether
they end up in the ganglion or nerve.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1.
Some opV placode cells are post-mitotic by HH8 (3–5ss). A–C. All cells are labeled in
embryos treated with 3H-Thy at HH7 (1ss) (collected at HH13 (18ss)). A. High power of
opV placode cell (arrowhead) delaminating at mid-midbrain (mMB) level. B–C. At rostral
hindbrain levels (rHB), spurs of cells delaminating from ectoderm were actively dividing at
HH7 (arrowhead). D. Diagram of HH12 (15ss) embryo showing relative location of HH8
(4ss) post-mitotic cells in ectoderm (red circles) and mesenchyme (green triangles). E–I.
Embryos treated with 3H-Thy at HH8 (4ss) (collected at HH12 (15ss)). E. Cluster of cells
(arrows) have exited cell cycle by HH8 (4ss) at caudal forebrain level. F–G. Individual cells
at rostral midbrain level have exited cell cycle and are delaminating. H. At mMB, a cell in
ectoderm has exited the cell cycle (arrow). I. At rHB, most cells are labeled; a spur of opV
cells actively dividing at HH8 (arrowhead). A–C, E–I. Large arrows indicate post-mitotic
cells and arrowheads indicate cells in S phase at time of initial 3H-Thy. ECTO=ectoderm,
NT=neural tube. Scale bars are approximately 10 µm.
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Figure 2.
Trigeminal placode extends into caudal forebrain level. A. At the forebrain/eye level, an
HH10 (9ss) embryo (collected at HH15 (25ss)) shows two post-mitotic cells (arrows) that
migrated to position of future opV nerve. B. Higher power of A. C. DiI label at HH11 (12ss)
(collected at HH14 (21ss)) shows delaminate placode cells at forebrain level (small arrow).
D. Embryo treated at HH9 (8ss) (collected at HH15 (26ss)) (same level as A,B) has two
NFM+/BrdU- cells. E. Higher power of D. F. DAPI of cells in E. G–I. Pax3, a marker for
specified trigeminal placode cells, is expressed at forebrain levels at HH9, 10, 11 (8ss, 11ss,
14ss). A–F. Large arrows indicate post-mitotic cells. G–I. Large arrow indicates Pax3+ cell
in ectoderm. FB=forebrain, cFB=caudal forebrain, HB=hindbrain. Scale bars are
approximately 10 µm. Magenta/green version (without DAPI triple label) can be found in
Supplemental Figure1.
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Figure 3.
Post-mitotic opV placode cells increase in number over time and become localized in
condensing opV ganglion and nerve. A–B. Between mid-eye level and opV ganglion region,
the number of post-mitotic cells within the forming opV nerve (B) by this stage are
increasing to 2–5 per section in an embryo treated at HH10 (9ss) and collected at HH15
(25ss). C–D. At a similar axial level in an older embryo treated at HH14 (22ss) and collected
at HH16 (28ss), additional post-mitotic cells can be found within the condensing opV nerve
approaching the ganglion region. E–G. As a comparison to C-D, this embryo was treated at
the same time as C–D at HH14 (23ss) but allowed to develop until HH18 (36ss). In a
longitudinal section at the level of the condensed trigeminal ganglion (contains opV and
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mmV cells at this level), post-mitotic cells are seen in the opV nerve (E) both rostral towards
the eye (F) and caudal at the ganglion edge (G). H. Hu+ neurons (white arrows) are shown
in the forming opV at the level of forebrain caudal to the eye at HH17 (29ss). I. Expression
of NF at level of opV nerve at HH24. J. Adjacent section of I shows NF expression within
opV nerve. K. Nerve cell bodies are Hu+ within the maturing opV nerve. A–G. Black
arrows indicate post-mitotic cells. ECTO= ectoderm, TG= trigeminal ganglion, FB=
forebrain, opVN= ophthalmic trigeminal nerve. Scale bars are approximately 10 µm.
Magenta/green version can be found in Supplemental Figure2.
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Figure 4.
opV placode cells that express Pax3 begin exiting cell cycle at HH8 (3–5ss). A–C. All
ectoderm cells that give rise to future Pax3+ opV placode cells are actively dividing at HH7
(2ss) (collected at HH10 (11ss)). Pax3 stains migrating neural crest in the mesenchyme at
HH10. D–F. Pax3+/BrdU- cells detected in the mesenchyme first treated at HH8 (5ss)
(collected at HH13 (19ss)) similar to embryo treated with 3H-Thy. G–I. More Pax3+/BrdU-
cells become detectable in a spur of delaminating cells when treated at HH9 (8ss) (collected
at HH16 (28ss)). J–L. Additional placode cells exiting the cell cycle by HH10 (11ss)
(collected at HH16 (28ss)). All sections at level of middle midbrain. BrdU (red;A,D,G,J);
Pax3 (green;B,E,H,K); Merge of BrdU, Pax3, DAPI (blue;C,F,I,L). Arrows indicate post-
mitotic cells and arrowheads indicate cells undergoing DNA synthesis at time of initial
BrdU application. Scale bars are approximately 10 µm. Magenta/green version (without
DAPI triple label) can be found in Supplemental Figure3.
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Figure 5.
opV placode cells that express NFM, begin exiting cell cycle at HH8 (3–5ss). A–C. A few
NFM+/BrdU- cells detected in embryos treated at HH8 (5ss) (collected at HH13 (18ss)). C’.
Higher power view of C showing NFM+/BrdU+ cell. C’’. Higher power view of C showing
NFM+/BrdU- cell. D–F. More NFM+/BrdU- cells in embryos treated at HH9 (8ss)
(collected at HH15 (26ss)). F’. Higher power view of F showing NFM+/BrdU- cell. F’’.
Higher power view of F showing NFM+/BrdU+ cell. G–I. Additional placode cells have
exited the cell cycle by HH10 (9ss) and express NFM (collected at HH15 (25ss)). I’. Higher
power view of I showing NFM+/BrdU- cell. I’’. Higher power view of I showing NFM+/
BrdU+ cell. Arrows indicate post-mitotic cells and arrowheads indicate cells undergoing
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DNA synthesis at time of initial BrdU application. BrdU (red;A,D,G); NFM (green;B,E,H);
Merge of BrdU, NFM, DAPI (blue;C,F,I). All sections at level of middle midbrain. Scale
bars are approximately 10 µm. Magenta/green version (without DAPI triple label) can be
found in Supplemental Figure4.
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Figure 6.
Pulse of BrdU shows opV placode cells that express neuronal markers have exited the cell
cycle. Embryos were exposed to a 30 minute pulse of BrdU immediately before fixation. A–
C. However, Pax3 expression does not necessarily correlate with cell cycle exit. At HH10
(10ss), opV placode cells in ectoderm express Pax3 (green) with (arrowhead) and without
(arrow) BrdU. D–F. At HH11 (13ss), NFM+ (green)/BrdU- cells are detected in ectoderm
and mesenchyme. G–I. By HH18 (33ss), opV placode cells condensing in opV ganglion are
Hu+ (green)/Brdu-(arrows). A–F at level of mid midbrain, G–I at level of caudal midbrain.
Scale bars are approximately 10 µm. Magenta/green version (without DAPI triple label) can
be found in Supplemental Figure5.
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